Investor Presentations
Presentation material used for investor briefings is posted below after release to the Australian Securities Exchange.
2nd
Nov 20
Investor Presentation
Investor Presentation:
- FDA Approval of Bronchitol Transforms Cash and Operations
- Breakthrough Clinical Program in Myelofibrosis
1st
May 20
Investor Presentation - 1 May 2020
Updated investor presentation
View presentation – pdf